1. Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
2. Food and Drug Administration. Developing antimicrobial drugs — general considerations for clinical trials (draft guidance for industry), 1998. http://www.fda.gov/cder/guidance/index.htm
3. Committee for Proprietary Medicinal Products. Note for guidance on evaluation of medicinal products indicated for the treatment of bacterial infections, CPMP/EWP/558/95, 2004. http://www.emea.eu.int/pdfs/human/ewp/055895en.pdf
4. Towards a targeted, risk-based, antifungal strategy in neutropenic patients
5. Clinical and Laboratory Standards Institute. Methods for the dilution antimicrobial susceptibility test for bacteria that grow aerobically, 6th edn. Approved Standard document M07. CLSI: Wayne, PA 2003.